GF
PTLA

Gabelli Funds’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Gabelli Funds’s Portfolio PTLA Stock Details PTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-909,260
Closed -$16.4M – 1191
2020
Q2 		$16.4M Buy
+909,260
New +$12.6M 0.13% 198

Gabelli Funds's PTLA Position: Q3 2020 in Review

Gabelli Funds sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q3 2020, closing a stake of 909,260 shares — an estimated $16.4M sold.

Gabelli Funds first reported a position in PTLA in Q2 2020 and held it in 1 quarter. The position peaked at $16.4M in Q2 2020. 0 funds tracked by Wall St. Rank hold PTLA as of Q3 2020.

  • Gabelli Funds reported no remaining Portola Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
  • Gabelli Funds sold 909,260 Portola Pharmaceuticals, Inc. shares in Q3 2020, an estimated $16.4M.
  • Gabelli Funds first reported a position in Portola Pharmaceuticals, Inc. in Q2 2020 and held it in 1 quarter.
  • Gabelli Funds's Portola Pharmaceuticals, Inc. position peaked at $16.4M in Q2 2020.
  • 0 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q3 2020.

Based on Gabelli Funds's 13F filing for Q3 2020, filed 6 Nov 2020.